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New vessel formation, or angiogenesis, is a pre-requisite for
tumour growth beyond 1–2 mm3 and for metastasis (Folkman,
1990, 1994). Assessment of angiogenesis in histological sections
by counting tumour microvessels has been shown to provide inde-
pendent prognostic information in the majority of studies in breast
cancer (Weidner et al, 1991; Horak et al, 1992; Gasparini et al,
1994).
This study addresses practical issues relating to methodology.
Not all studies have found microvessel counts to be of prognostic
value (Van Hoef et al, 1993; Axelsson et al, 1995; Costello et al,
1995), which may be due in part to problems with reproducibility.
Individual investigator experience affects results (Vermeulen et al,
1997) and other studies have found high rates of inter-observer
variation (Van Hoef et al, 1993; Axelsson et al, 1995).
Heterogeneity of vasculature in breast tumours is well recog-
nized (Weidner et al, 1991; Van Hoef et al, 1993) and has led to the
recommendation of selection of areas of highest vascularity or ‘hot
spots’ in which to perform microvessel counts. This is based on
the rationale that it is the highly angiogenic tumour cell clones that
are most likely to behave aggressively and to metastasize (Weidner
et al, 1992; Vermeulen et al, 1996). A transverse tumour section
has been found to be representative of whole tumour when
microvessel counts in vascular ‘hot spots’ were compared with
radiological grades from micro-angiographic assessments of the
same tumours (Martin et al, 1997b). However, another study
addressing similar issues found noteworthy heterogeneity of
microvessel counts between different areas of the same tumour
and emphasized the need for careful ‘hot spot’ selection (de Jong
et al, 1995). Attempts have been made to improve objectivity of
the counting method with use of a Chalkley eyepiece graticule or
computerized image analysis (Fox et al, 1995).
As an increasing number of patients undergo primary systemic
treatment prior to tumour excision, the only specimen available for
studies of potentially useful prognostic and predictive markers are
core needle biopsies. Such core biopsies provide useful histo-
logical information (Minkowitz et al, 1986), but such material may
not be representative of overall tumour vascularity (Jacobs et al,
1998). In addition, effects of previous surgical manipulations on
tumour vascularity assessment have not been addressed.
The aims of the present study were: (i) to assess intra-observer
and inter-observer variation in microvessel counts; (ii) to deter-
mine whether core biopsies are representative of whole tumour;
(iii) to investigate effects of previous surgical manipulation on
subsequent biopsies.
MATERIALS AND METHODS
Patient material
Core biopsies
Biopsies were performed following infiltration of the area with
20 ml 1% lignocaine with 1:200 000 adrenaline via a single stab
incision at a point lateral to the lesion. Between one and seven
biopsies were performed using a Pro-Mag gun and 14-gauge
needle.
Tumour sections
Immediately following surgical excision, complete transverse
sections of tumour were collected, including central and peripheral
tumour areas.
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Study design
Three comparative studies were performed:
1. In 16 excised tumours, core biopsies were taken and tumour
sections obtained at the same time. This allowed direct
comparison of counts performed on core biopsies and sections
taken simultaneously.
2. Twenty-one patients with newly diagnosed breast cancer
underwent core biopsies for confirmation of diagnosis and
determination of oestrogen receptor status. Following surgical
excision of tumour between 5 and 35 days later, transverse
tumour sections were collected. This allowed comparison of
counts performed on core biopsies and tumour sections taken
at a later time with no intervening treatment.
3. In ten cases, core biopsies were performed at diagnosis and
repeated immediately following surgical excision, between
5 and 25 days later, thus allowing comparison of counts on
core biopsies from the same tumour taken at different times.
Tumour preparation
All specimens were fixed in formalin for a minimum period of
24 h and paraffin-embedded. Four-micrometre sections were cut
and a section of each sample stained with haematoxylin and eosin
for histological assessment.
Immunohistochemistry
Immunohistochemistry was performed following antigen retrieval
with protease using anti-CD31 antibody (Dako) (Parums et al,
1990). The alkaline phosphatase anti-alkaline phosphatase
(APAAP) technique was used to visualize antibody binding
(Cordell et al, 1984).
Microvessel counts
Following staining with CD31 the three areas of highest vascu-
larity were identified by scanning sections at low power (´40 and
´100). Counts were performed at high power (´250) using a
Chalkley 25-point eyepiece graticule. In these areas, the graticule
was oriented so that the maximum number of points lay on or
within areas of highlighted vessels. Microvessel count (mvc) was
taken as the total of three counts. All counts were performed using
a conference microscope with two observers, a pathologist (KK)
and a surgeon (LM) who had undergone a period of training in the
technique. In addition, the individual investigators performed
separate counts on 16 tumours to assess interobserver variability
and together repeated counts on 31 tumours at different times to
assess intra-observer variation.
Statistical analysis
Comparisons of pairs were made using Wilcoxon rank test. An
expression of variation was calculated for intra- and inter-observer
variation, as the standard deviation of the difference between two
groups/mean of total. Correlations were determined using the
Spearman rank correlation test.
RESULTS
Intra- and inter-observer variation
Microvessel counts performed by the same observers on two
occasions (mvc1 and mvc2) at least a fortnight apart were
compared in 31 tumours, of which 16 were core biopsies.
Correlation between counts is illustrated in Figure 1. Mvc1 ranged
from 12 to 28 (median: 16, mean: 16.4) and mvc2 from 14 to 28
(median: 17, mean: 17.7). There was significant correlation
between the two counts (r = 0.84, P < 0.001). The standard devia-
tion of difference between the two groups was 1.95, giving an
expression of variation of 11%.
Microvessel counts were performed by two different observers
(mvcKK and mvcLM) in 16 tumours, all of which were tumour
sections. MvcKK ranged from 12 to 28 (median: 20, mean: 20.3),
mvcLM ranged from 13 to 31 (median: 19.5, mean: 20.5) as
shown in Figure 2. A significant correlation was found between
30
25
20
15
10
5
0
0 5 10 15 20 25 30
MVCI
M
V
C
2
35
30
25
20
15
10
5
0
0 5 10 15 20 25 30
MVC KK
M
V
C
 
L
M
35
Figure 1 Correlation of counts at different time points, where mvcl is the
first count and mvc2 is the second (Spearman rank correlation: r = 0.84,
P < 0.001)
Figure 2 Correlation of counts performed by different observers, where
mvcKK is the count performed by Dr Kurian and mvcLM is the count
performed by Miss Marson (Spearman rank correlation: r = 0.83, P < 0.001)1090 LP Marson et al
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counts of the two observers (r= 0.83, P< 0.001). The standard
deviation of differences was 3.03, giving an expression of varia-
tion of 15%.
Comparison between mvc of core biopsies and tumour
cross-section from excised tumours
Core biopsies were taken of 16 tumours immediately following
surgical excision. The number of core biopsies taken from each
tumour ranged from 1 to 7 (median: 3, mean: 3.3). Figure 3 illustrates
immunohistochemical staining of vessels with antibody to CD31 in a
core biopsy section (Figure 3A) and tumour section (Figure 3B).
Figure 4 illustrates the correlation between counts in cores and
tumour sections. Mvc in core biopsies ranged from 13 to 22
(median: 17, mean: 16.5) and in tumour sections from 14 to 24
(median; 18, mean: 18). There was no significant difference in
mvc between the two groups (P= 0.1, paired Wilcoxon).
Conversely whilst there was a positive correlation in counts, this
just failed to reach statistical significance (r= 0.44, P= 0.09). Mvc
was higher in tumour sections than core biopsies in nine of 16
tumours (56%), was higher in core biopsies in three of 16 tumours
(18.8%) and the same in four (25%).
Comparison between mvc of core biopsy and
subsequent tumour cross-section
Core biopsies were taken for diagnosis in 21 patients who under-
went surgery between 5 and 34 days later (median time to surgery:
23 days), with no intervening treatment. One patient was found to
have carcinoma in situ with no evidence of invasion and was
excluded from the study. The number of core biopsies taken
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Figure 3(A) Illustration of immunohistochemical staining with antibody to
CD31 performed on a core biopsy section. (B) Illustration of
immunohistochemical staining with antibody to CD31 performed on a cross-
section of the same tumour, with vessels highlighted in red against a
background of haematoxylin counterstaining
Figure 4Relationship between microvessel count of cores and tumour
sections taken simultaneously (Spearman rank correlation: r = 0.44,
P= 0.09)
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Figure 5Relationship between mvc of cores and subsequent tumour
sections (Spearman rank correlation: r = 0.1, P > 0.05, paired Wilcoxon:
P= 0.0065)Microvessel counts in breast cancer1091
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ranged from 1 to 6 (median: 3, mean: 2.95). Transverse sections of
the same tumours were taken at surgery.
The relationship between counts of cores and subsequent
tumour cross-sections is shown on Figure 5. Microvessel counts in
core biopsies ranged from 12 to 25 (median: 16, mean: 17.1) and
in later tumour cross-sections from 15 to 25 (median: 21, mean:
21.1). Although the range of mvc values in cores and subsequently
excised material was similar, there was no significant correlation
between them (r= –0.1). There was a significant difference in
counts in the two sample types with values tending to be higher in
tumour sections than core biopsies (P= 0.0065, paired Wilcoxon).
This was reflected in 13 of 20 tumours (65%) in which counts
were higher in tumour sections than cores, in four of 20 tumours
(20%) counts were higher in core biopsies and identical values
were obtained in three tumours (15%).
Comparison between mvc of core biopsies at diagnosis
and following surgical excision
Multiple core biopsies were taken of tumours in ten patients for
diagnosis and were repeated immediately following surgical exci-
sion. The number of cores performed ranged from 1 to 7 (median:
3, mean: 3.05). Figure 6 illustrates the relationship between counts
in cores at the two time points. Mvc in cores at diagnosis (mvc1)
ranged from 10 to 22 (mean 16.4, median 16.5) and in cores at
surgery (mvc2) ranged from 13 to 21 (mean: 17.4, median: 18). No
significant association was found between counts in the pairs of
cores (r= –0.38). Conversely, no significant difference in mvc was
detected (P= 0.48), with counts being higher in later cores in five
of 10 tumours (50%), higher in initial biopsies in four tumours
(40%) and the same in one (10%).
Correlation between number of cores performed and
Codifference in mvc between cores and tumour section
Analysis was performed to determine whether there was a
relationship between number of cores performed and the difference
in mvc between cores and tumour sections. In 37 cases, cores and
tumour section were available for comparison. Number of cores
performed ranged from 1 to 7 (median: 3, mean: 3.13). Mvc differ-
ence was expressed as a percentage of total mvc count in the
tumour section, and its relationship with number of cores is
illustrated on Figure 7. No significant correlation was identified
(r= –0.25, P> 0.05).
DISCUSSION
The present study has attempted to assess the variation in assess-
ment of angiogenesis which might be caused by (i) inherent
variation in the method, (ii) tumour heterogeneity and (iii)
previous surgical manipulation of tumour.
Variation in mvc between the same observers performed at
different times was 11% in this study, with a highly significant
correlation between the two sets of counts (r= 0.84, P< 0.001).
Inter-observer variation was 15%, which is comparable to another
study addressing the same issue (Martin et al, 1997a). The issues
of observer variation have been raised in several studies as a
possible reason for failure of angiogenesis assessment to provide
useful prognostic information in some series of primary breast
cancers (Van Hoef et al, 1993; Axelsson et al, 1995). In both
studies, mvc was used as a categorized rather than a continuous
variable (Van Hoef et al, 1993; Axelsson et al, 1995), which may
result in loss of predictive power (Vermeulen et al, 1996). Another
study addressing the issue of observer variation found that mvc
provided independent prognostic information in a series of breast
tumours when performed by experienced observers, but not by the
least experienced observer (Vermeulen et al, 1997). The authors
therefore recommended a period of training with an experienced
observer (Vermeulen et al, 1997). In the present study, counts were
performed by two observers, a pathologist and a surgeon, who had
undertaken a period of training with an experienced observer
before embarking on the study. Other methods have been
suggested to improve objectivity of the counting method, such as
use of a Chalkley eyepiece graticule, as described in the present
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Figure 6Relationship between mvc performed on core biopsies taken at
separate time points, where mvc of cores 1 are counts on the first set of
cores and mvc of cores 2 counts on the second set (Spearman rank
correlation: r = 0.38, P = 0.48)
Figure 7Percentage difference in mvc between two tumour samples
versus number of cores taken (Spearman rank correlation: r = 0.25,
P> 0.05)1092 LP Marson et al
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study, or computerized image analysis (Fox et al, 1995). In a
recently published study comparing inter-observer variability
using different counting methods, use of the Chalkley grid yielded
low variability and was found to be more effective in reducing
variation than selection of the same hot spot by different observers
(Hansen et al, 1998). Reproducibility was further optimized by the
use of a conference microscope, thereby eliminating subjectivity
in hot spot selection and field sampling (Hansen et al, 1998). The
low degree of inter-observer variability observed in the present
study is likely to be related to the use of the Chalkley grid by two
observers using a conference microscope.
Tumour heterogeneity in vasculature was investigated in the
present study by comparing microvessel counts in core biopsies
and tumour sections taken simultaneously. Whilst the range of
counts was similar in the two groups, correlation between counts
failed to reach statistical significant (r = 0.44, P = 0.09). Vessel
counts in tumour sections tended to be higher than those in core
biopsies. Heterogeneity of tumour vasculature between different
areas of the same tumour is well-recognized (Weidner et al, 1991;
Van Hoef et al, 1993) and is overcome to an extent by selection of
three vascular ‘hot spots’. Alternatives to the original method
proposed by Weidner have been suggested and may particularly
benefit the less experienced observer. These are to perform counts
in ten fields of high vascularity, taking the highest count as the
mvc (Martin et al, 1997a), or to perform photomicrographs of the
most intensely vascular areas and for individual observers to
obtain counts from the photographs (Vermeulen et al, 1997). Core
biopsies represent only a small cross-section of total tumour and
are therefore less likely to include individual vascular ‘hot spots’
than a larger tumour section. Indeed, in some core biopsy speci-
mens it was difficult to clearly identify three hot spots. The differ-
ences in vessel density in ‘hot spots’ found in core biopsies and
tumour sections are illustrated on Figure 3, which clearly shows a
lower density in the core biopsy compared with the tumour
section. These observations were further borne out in the findings
that counts in core biopsies were lower than those in tumour
sections in 65% of tumours and higher in only 20%. Another study
which addressed the role of core biopsies found a similar lack of
correlation in mvc of cores and tumour sections, but found mvc to
be higher in core biopsies than tumour sections in 61.2% of cases
(Jacobs et al, 1998).
Problems with tumour heterogeneity are not unique to vascular
assessments, but have been described for several other parameters
in breast cancer. Significant variations in mitotic activity index
assessed on haematoxylin and eosin sections (Jannink et al, 1996)
and DNA cell cycle variables (Bergers et al, 1996) were found on
assessment of multiple tumour sections. Conversely, levels of
MIB-1 and oestrogen receptor expression were found to alter little
in assessments of serial tumour sections (Jensen and Ladekarl,
1995).
The issue of the accuracy of core biopsies in providing prog-
nostic information is important as such specimens are increasingly
used in diagnosis and may provide the only pretreatment tissue
available. Other studies have addressed similar issues for markers
other than angiogenesis and reproducible results have been
obtained for determinations of DNA ploidy, bcl-2, oestrogen
receptor, c-erbB-2 and p53, which are dichotomously scored
variables (Daidone et al, 1991; Jacobs et al, 1998). Jacobs et al
failed to produce reproducible results for mvc and accuracy was
not improved by increasing tumour area available for assessment
by performing more core biopsies (Jacobs et al, 1998). This is in
keeping with results from the present study, in which, whilst there
is a suggestion from Figure 6 that difference in mvc may be
reduced with an increasing number of core biopsies, this correla-
tion failed to reach statistical significance.
Another possible reason for unreliability of sequential core
biopsies in tumour vascular assessment is the likely induction of
angiogenesis following initial biopsy as part of the normal process
of wound healing (Folkman, 1971). Comparison of mvc in core
biopsies and subsequent tumour sections and in sequential core
biopsies with no intervening treatment failed to show any correla-
tion (Figures 4 and 5), which may be due to inherent variability in
vessels throughout the tumour and/or effects of previous surgical
manipulation.
In summary, this study has addressed various practical issues
regarding the methodology of tumour vascularity assessment by
mvc. Intra- and inter-observer variation in counts were 11 and 15%
respectively, which were similar to results of other studies.
Tumour heterogeneity is a problem when adopting this method in
small tumour biopsies, such as core biopsies, which may not
contain vascular ‘hot spots’. In addition, angiogenesis takes place
in conditions other than tumour growth, such as wound healing
and is therefore likely to be stimulated by surgical manipulation of
the tumour, affecting subsequent assessments. Results of the
present study suggest that mvc on core biopsy specimens are
unlikely precisely to represent overall tumour vascularity. Other
markers of angiogenesis, such as angiogenic growth factor expres-
sion, which may be assessed in tumour or serum, may provide an
alternative method of assessment. These may be less subject to
such variations, as the methods involved are not dependent on
selection of specific tumour areas for assessment.
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